Drug Regimen Compliance: Issues in Clinical Trials and Patient Management Book + PRICE WATCH * Amazon pricing is not included in price watch

Drug Regimen Compliance: Issues in Clinical Trials and Patient Management Book

Drug Regimen Compliance Issues in Clinical Trials and Patient Management Edited by Jean-Michel Métry Aardex Ltd., Zug, Switzerland and Urs A. Meyer University of Basel, Switzerland A patient's non-compliance with drug regimens can render drugs ineffective. This not only causes problems for the patient but also large costs for health services. Despite a renewed interest in the subject over the past few years, there is still a dearth of new ideas and perspectives. This volume is written in response to this lack, and seeks to: * Address key topics, such as regulatory issues and the role of compliance in clinical care * Provide pointers for trials * Provide guidelines for the management of patients * Explore means by which compliance can be monitored * Suggest the best ways to monitor patient management Drug Regimen Compliance: Issues in Clinical Trials and Patient Management provides the basis for future steps in improving patient compliance and will be invaluable to pharmacologists, toxicologists, pharmaco-epidemiologists, clinical trial scientists, medical economists and all those prescribing drug regimens.Read More

from£N/A | RRP: £153.00
* Excludes Voucher Code Discount Also available Used from £N/A
  • 0471971227
  • 9780471971221
  • 30 January 1998
  • CRC Press
  • Hardcover (Book)
  • 199
  • 1
As an Amazon Associate we earn from qualifying purchases. If you click through any of the links below and make a purchase we may earn a small commission (at no extra cost to you). Click here to learn more.

Would you like your name to appear with the review?

We will post your book review within a day or so as long as it meets our guidelines and terms and conditions. All reviews submitted become the licensed property of www.find-book.co.uk as written in our terms and conditions. None of your personal details will be passed on to any other third party.

All form fields are required.